SCHEMBL31688341

SCHEMBL31688341

CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O

nearest known ligand 0.64

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.64
▸ OPRM1 P35372 1/20 0.59
▸ OPRD1 P41143 1/20 0.59
▸ OPRK1 P41145 1/20 0.59
▸ IL23R Q5VWK5 6/20 0.58
▸ VIPR1 P32241 1/20 0.58
▸ NR3C1 P04150 2/20 0.56
▸ VIPR2 P41587 1/20 0.55
▸ ECE1 P42892 1/20 0.55
▸ GLP1R P43220 1/20 0.55
▸ MUS81 Q96NY9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38662535 0.93 OPRM1 (0.61) TFPIOPRM1OPRD1OPRK1
SCHEMBL30435345 0.91 TFPI (0.71) TFPIVIPR1NR3C1VIPR2ECE1
SCHEMBL30880895 0.91 OPRM1 (0.60) TFPIOPRM1OPRD1OPRK1IL23R
SCHEMBL30880902 0.91 OPRM1 (0.63) TFPIOPRM1OPRD1OPRK1IL23R
SCHEMBL29721606 0.90 TFPI (0.57) TFPIOPRM1OPRD1OPRK1IL23R
SCHEMBL31742547 0.89 TFPI (0.58) TFPIIL23R
SCHEMBL30669462 0.89 NPY4R (0.62) TFPIVIPR1
SCHEMBL30669464 0.89 NPY4R (0.62) TFPIVIPR1
SCHEMBL31000924 0.88 TFPI (0.64) TFPIOPRM1OPRD1OPRK1VIPR1
SCHEMBL29903297 0.88 TFPI (0.71) TFPIVIPR1NR3C1VIPR2ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250297282-A1 VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE JUNO THERAPEUTICS GMBH (DE) 2025-09-25 — — US disclosed
Send feedback